Who is sponsoring NCT02302183?

NCT02302183 is sponsored by University Hospital, Brest.

What drugs are being tested in NCT02302183?

Interventions in NCT02302183: FreeO2 v2.0 automatic adjustment, FreeO2 v2.0 data collecting.

What condition does NCT02302183 study?

NCT02302183 studies Hypoxemic Acute Respiratory Distress, Infant Between 1 Month and 24 Months Old, Child Between 2 and 15 Years Old.

Is NCT02302183 still recruiting?

NCT02302183 is currently completed. Last updated 3 March 2017.

Last reviewed 2017-03-03 · How we verify

NCT02302183: Infant-Free02

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Automatic Oxygen Administration During the Respiratory Distress in Infants and Children (Infant-FreeO2)

Completed NA Last updated 3 March 2017

What this trial tests

NA trial testing FreeO2 v2.0 automatic adjustment in Hypoxemic Acute Respiratory Distress in 60 participants. Completed in 23 February 2017.

Timeline

24 December 2014

Primary endpoint
23 February 2017

23 February 2017

Quick facts

Lead sponsor	University Hospital, Brest
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	60
Start date	24 December 2014
Primary completion	23 February 2017
Estimated completion	23 February 2017
Sites	1 location across France

Drugs / interventions tested

FreeO2 v2.0 automatic adjustment
FreeO2 v2.0 data collecting

Conditions studied

Hypoxemic Acute Respiratory Distress — all drugs for Hypoxemic Acute Respiratory Distress →
Infant Between 1 Month and 24 Months Old — all drugs for Infant Between 1 Month and 24 Months Old →
Child Between 2 and 15 Years Old — all drugs for Child Between 2 and 15 Years Old →

Sponsor

University Hospital, Brest

Who can join

Adults 1 Month to 15, any sex, with Hypoxemic Acute Respiratory Distress or Infant Between 1 Month and 24 Months Old. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to assess the use feasibility of the FreeO2 system so as to deliver automatically oxygen in infants and children admitted at hospital for hypoxemic acute respiratory distress. In healthy volunteers adults, FreeO2 system provided a better control of the oxygen saturation in function of designed target, reducing the desaturation time and hyperoxia. Our hypothesis is that FreeO2 system use is feasible in infants and children with hypoxemic acute respiratory distress. We think FreeO2 will provide a better control of the oxygen saturation, a faster oxygen weaning than classical way (Rotameter). In addition, FreeO2 could reduce the number of intervention by nurses.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Automated oxygen delivery for preterm infants with respiratory dysfunction.
Stafford IG, Lai NM, Tan K. · · 2023 · cited 13× · PMID 38032241 · DOI 10.1002/14651858.cd013294.pub2

Verify or expand the search:

Other University Hospital, Brest trials

Trials by the same sponsor.

NCT07526688 — Aerobic Physical Activity and Orofacial Myofascial Pain · NA · not yet recruiting
NCT07487155 — Unified Junction of Care, Integrated Treatments and Team Coordination for ADHD in Prison Settings With Substance Use Dis · NA · not yet recruiting
NCT07417605 — Diagnostic Performance Of 4D Dynamic LAFOV FDG-PET Acquisition for Differentiation of Residual Disease and Post-radiatio · not yet recruiting
NCT07302074 — Understanding of Rare Inflammatory Arthritis in Comparison to Classical Inflammatory Arthritis : Tissular Observations a · NA · recruiting
NCT06441773 — Impact of Respiratory Rehabilitation on Quality of Life in Patients With Metastatic Non-small Cell Lung Cancer Treated W · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02302183 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Brest
Last refreshed: 3 March 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02302183.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing